Join

Compare · DHAC vs OPCH

DHAC vs OPCH

Side-by-side comparison of Digital Health Acquisition Corp. (DHAC) and Option Care Health Inc. (OPCH): market cap, price performance, sector, and recent activity on the wire.

Summary

  • Both DHAC and OPCH operate in Medical/Nursing Services (Health Care), so they compete in similar markets.
  • OPCH is the larger of the two at $4.09B, about 27.6x DHAC ($148.1M).
  • OPCH has hit the wire 4 times in the past 4 weeks while DHAC has been quiet.
  • OPCH has more recent analyst coverage (13 ratings vs 0 for DHAC).
MetricDHACOPCH
Company
Digital Health Acquisition Corp.
Option Care Health Inc.
Price
$13.11+8.76%
$28.41-0.49%
Market cap
$148.1M
$4.09B
1M return
-
-
1Y return
-
-
Industry
Medical/Nursing Services
Medical/Nursing Services
Exchange
NASDAQ
NASDAQ
IPO
2021
News (4w)
0
4
Recent ratings
0
13
DHAC

Digital Health Acquisition Corp.

Digital Health Acquisition Corp. does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or other similar business combination with one or more businesses or entities. It intends to focus on technology and healthcare focused businesses. The company was incorporated in 2021 and is based in Boca Raton, Florida.

OPCH

Option Care Health Inc.

Option Care Health, Inc. offers home and alternate site infusion services in the United States. The company provides immunoglobulin infusion therapies for the treatment of immune deficiencies; anti-infective therapies and services; home infusion services to treat heart failures; and treatments for chronic inflammatory disorders, including Crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders; and immunoglobulin infusion therapies. It also offers infusion therapies for bleeding disorders; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; and other infusion therapies to treat various conditions, including pain management, chemotherapy, and respiratory medications. In addition, the company offers therapies that women need to survive and thrive through high-risk pregnancies; treatments to manage the progression of neurological disorders, such as amyotrophic lateral sclerosis and duchenne muscular dystrophy; and nursing services. The company is headquartered in Bannockburn, Illinois.

Latest DHAC

Latest OPCH